PSTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Poseida Therapeutics Insider Trading History Chart

Poseida Therapeutics Share Price & Price History

^$2.05

▼ -0.02 (-0.97%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

The “Next Bitcoin”? 10 CENT Crypto Set to Explode

From True Market Insiders | Ad

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

Poseida Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/8/2022	Eric Ostertag	Chairman	Buy	142,857	$3.50	$499,999.50	838,824
8/8/2022	Life Sciences Holdings L Malin	Major Shareholder	Buy	2,150,000	$3.50	$7,525,000.00	11,835,673
8/3/2022	Eric Ostertag	Chairman	Sell	160,696	$3.69	$592,968.24	695,967
3/16/2022	Kerry D. Ingalls	COO	Buy	3,000	$3.98	$11,940.00
12/6/2021	Life Sciences Holdings L Malin	Director	Buy	1,828	$6.90	$12,613.20
12/1/2021	Life Sciences Holdings L Malin	Director	Buy	18,365	$6.85	$125,800.25
11/29/2021	Life Sciences Holdings L Malin	Director	Buy	11,057	$6.89	$76,182.73
11/26/2021	Life Sciences Holdings L Malin	Director	Buy	27,251	$6.81	$185,579.31
11/23/2021	Life Sciences Holdings L Malin	Director	Buy	14,625	$6.77	$99,011.25
11/18/2021	Life Sciences Holdings L Malin	Director	Buy	71,312	$7.18	$512,020.16
11/17/2021	Kerry D. Ingalls	COO	Buy	2,000	$7.00	$14,000.00
11/16/2021	Life Sciences Holdings L Malin	Director	Buy	27,680	$7.17	$198,465.60
11/8/2021	Eric Ostertag	CEO	Sell	18,924	$7.09	$134,171.16
10/1/2021	Eric Ostertag	CEO	Sell	20,029	$7.02	$140,603.58
9/20/2021	Eric Ostertag	CEO	Sell	20,000	$8.00	$160,000.00
9/14/2021	Eric Ostertag	CEO	Sell	20,000	$8.14	$162,800.00
8/20/2021	Matthew A. Spear	Insider	Sell	4,000	$8.79	$35,160.00	45,485
7/1/2021	Eric Ostertag	CEO	Sell	20,563	$9.77	$200,900.51
6/11/2021	Matthew A. Spear	Insider	Sell	4,000	$9.44	$37,760.00	20,485
6/1/2021	Eric Ostertag	CEO	Sell	41,194	$8.61	$354,680.34	542,985
5/3/2021	Eric Ostertag	CEO	Sell	18,326	$9.01	$165,117.26	542,985

The “Next Bitcoin”? 10 CENT Crypto Set to Explode

From True Market Insiders | Ad

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

SEC Filings (Institutional Ownership Changes) for Poseida Therapeutics (NASDAQ:PSTX)

46.87% of Poseida Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Poseida Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/16/2024	Public Employees Retirement System of Ohio	22,700	$76K	0.0%	N/A	0.024%
2/15/2024	Cantor Fitzgerald L. P.	50,205	$0.17M	0.0%	N/A	0.053%
2/13/2024	Tower Research Capital LLC TRC	10,679	$36K	0.0%	+110.5%	0.011%
2/9/2024	Dynamic Technology Lab Private Ltd	10,459	$36K	0.0%	N/A	0.011%
2/1/2024	New York State Common Retirement Fund	22,763	$76K	0.0%	-44.1%	0.024%
2/1/2024	MCF Advisors LLC	247,024	$0.83M	0.1%	+476.4%	0.258%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	114,011	$0.38M	0.0%	-56.1%	0.119%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	342,857	$0.82M	0.0%	+186.7%	0.394%
11/13/2023	Acadian Asset Management LLC	851,839	$2.03M	0.0%	-23.4%	0.980%
11/13/2023	Silverarc Capital Management LLC	3,567,985	$8.49M	2.6%	+21.1%	4.105%
11/13/2023	FMR LLC	13,037,429	$31.03M	0.0%	+0.2%	14.999%
11/9/2023	Blair William & Co. IL	740,650	$1.76M	0.0%	+30.2%	0.852%
11/7/2023	Barclays PLC	45,542	$0.11M	0.0%	+40.7%	0.052%
11/6/2023	Keystone Financial Group	15,000	$36K	0.0%	N/A	0.017%
10/27/2023	Allspring Global Investments Holdings LLC	12,247	$29K	0.0%	N/A	0.014%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	259,929	$0.62M	0.0%	+10.2%	0.299%
10/26/2023	Strs Ohio	20,100	$47K	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	32,368	$57K	0.0%	-68.4%	0.037%
9/8/2023	Tucker Asset Management LLC	19,096	$34K	0.0%	+156.2%	0.022%
8/15/2023	Silverarc Capital Management LLC	2,945,948	$5.19M	1.6%	+9.5%	3.389%
8/14/2023	Graham Capital Management L.P.	19,038	$34K	0.0%	N/A	0.022%
8/11/2023	Penserra Capital Management LLC	49,027	$86K	0.0%	+142.6%	0.056%
8/7/2023	Acadian Asset Management LLC	1,111,372	$1.95M	0.0%	+9.9%	1.281%
8/4/2023	American International Group Inc.	32,712	$58K	0.0%	N/A	0.038%
8/3/2023	Mackenzie Financial Corp	18,832	$33K	0.0%	N/A	0.022%
7/25/2023	DekaBank Deutsche Girozentrale	100,000	$0.16M	0.0%	+25.0%	0.115%
7/10/2023	SG Americas Securities LLC	31,016	$55K	0.0%	+29.4%	0.036%
6/13/2023	Callan Capital LLC	68,007	$0.21M	0.0%	+9.1%	0.078%
5/15/2023	Globeflex Capital L P	91,246	$0.28M	0.0%	N/A	0.105%
5/11/2023	Acadian Asset Management LLC	1,011,383	$3.12M	0.0%	+406.8%	1.166%
5/11/2023	Cornercap Investment Counsel Inc.	41,008	$0.13M	0.0%	-38.0%	0.047%
5/11/2023	Knott David M Jr	140,921	$0.43M	0.2%	-16.5%	0.162%
5/9/2023	Y Intercept Hong Kong Ltd	43,321	$0.13M	0.0%	N/A	0.050%
5/9/2023	Callan Capital LLC	68,007	$0.21M	0.0%	+9.1%	0.078%
5/4/2023	Barclays PLC	102,545	$0.32M	0.0%	+76.5%	0.118%
5/3/2023	Jump Financial LLC	122,091	$0.38M	0.0%	+88.1%	0.141%
5/1/2023	Virtu Financial LLC	22,806	$70K	0.0%	+28.2%	0.026%
4/28/2023	SG Americas Securities LLC	23,960	$74K	0.0%	N/A	0.028%
4/27/2023	Arizona State Retirement System	13,697	$42K	0.0%	N/A	0.016%
4/24/2023	Penserra Capital Management LLC	20,210	$62K	0.0%	-29.3%	0.023%
4/12/2023	FNY Investment Advisers LLC	10,000	$30K	0.0%	N/A	0.012%
2/14/2023	683 Capital Management LLC	36,966	$0.20M	0.0%	N/A	0.043%
2/13/2023	Callan Capital LLC	62,347	$0.33M	0.0%	N/A	0.073%
2/13/2023	GSA Capital Partners LLP	95,469	$0.51M	0.1%	N/A	0.111%
2/13/2023	Knott David M Jr	168,839	$0.90M	0.3%	+11.6%	0.196%
2/10/2023	HRT Financial LP	200,351	$1.06M	0.0%	N/A	0.233%
2/10/2023	Blair William & Co. IL	19,143	$0.10M	0.0%	+8.5%	0.022%
2/9/2023	Citigroup Inc.	163,675	$0.87M	0.0%	+5,651.1%	0.190%
2/1/2023	Bank of Montreal Can	399,472	$1.62M	0.0%	-22.9%	0.465%
1/31/2023	MCF Advisors LLC	42,854	$0.23M	0.0%	-17.4%	0.050%
11/15/2022	Perceptive Advisors LLC	750,000	$2.65M	0.1%	N/A	0.873%
11/15/2022	EcoR1 Capital LLC	2,650,000	$9.36M	0.3%	N/A	3.083%
11/14/2022	Pentwater Capital Management LP	5,975,000	$21.09M	0.2%	+20.3%	7.222%
11/14/2022	Cormorant Asset Management LP	1,850,000	$6.53M	0.5%	N/A	2.236%
11/14/2022	Ergoteles LLC	93,842	$0.33M	0.0%	-31.2%	0.113%
11/14/2022	Penserra Capital Management LLC	71,587	$0.25M	0.0%	N/A	0.087%
11/14/2022	Crown Advisors Management Inc.	150,000	$0.53M	0.5%	N/A	0.181%
11/14/2022	Forefront Analytics LLC	15,650	$59K	0.0%	-33.0%	0.019%
11/10/2022	Bank of Montreal Can	517,900	$2.10M	0.0%	N/A	0.626%
11/9/2022	MCF Advisors LLC	51,854	$0.18M	0.0%	-13.1%	0.063%
11/8/2022	Atom Investors LP	152,120	$0.54M	0.2%	+172.5%	0.184%
11/4/2022	Prudential Financial Inc.	12,600	$44K	0.0%	N/A	0.015%
11/2/2022	DekaBank Deutsche Girozentrale	80,000	$0.26M	0.0%	N/A	0.097%
10/28/2022	Silverarc Capital Management LLC	2,554,277	$9.02M	3.0%	+571.1%	3.088%
8/16/2022	Corton Capital Inc.	14,978	$39K	0.0%	-74.2%	0.018%
8/16/2022	Delphia USA Inc.	15,799	$41K	0.0%	-61.2%	0.019%
8/15/2022	Laurion Capital Management LP	545,700	$1.41M	0.0%	N/A	0.660%
8/10/2022	Forefront Analytics LLC	23,370	$61K	0.0%	-12.7%	0.037%
7/25/2022	Silverarc Capital Management LLC	380,606	$0.98M	0.3%	+58.8%	0.607%
5/23/2022	Cantor Fitzgerald L. P.	30,205	$0.14M	0.0%	+19.8%	0.048%
5/12/2022	Martingale Asset Management L P	16,116	$73K	0.0%	-32.0%	0.026%
5/9/2022	Forefront Analytics LLC	26,770	$0.12M	0.0%	+152.1%	0.043%
5/5/2022	MCF Advisors LLC	57,469	$0.26M	0.0%	N/A	0.092%
5/5/2022	Russell Investments Group Ltd.	9,407	$42K	0.0%	-66.6%	0.015%
4/29/2022	Nisa Investment Advisors LLC	13,000	$58K	0.0%	N/A	0.021%
4/19/2022	Regent Investment Management LLC	20,922	$94K	0.0%	-16.3%	0.033%
2/14/2022	Blair William & Co. IL	48,963	$0.33M	0.0%	N/A	0.078%
2/14/2022	GSA Capital Partners LLP	84,701	$0.58M	0.1%	N/A	0.136%
2/8/2022	Northern Trust Corp	251,793	$1.72M	0.0%	-2.0%	0.403%
2/2/2022	New York State Common Retirement Fund	11,972	$82K	0.0%	-42.1%	0.019%
1/21/2022	Russell Investments Group Ltd.	28,178	$0.19M	0.0%	-25.2%	0.045%
1/18/2022	Central Bank & Trust Co.	7,608	$52K	0.0%	+1,579.5%	0.012%
11/17/2021	Altium Capital Management LP	32,238	$0.24M	0.1%	N/A	0.052%
11/16/2021	Schonfeld Strategic Advisors LLC	289,179	$2.11M	0.0%	+13.6%	0.463%
11/16/2021	Millennium Management LLC	909,856	$6.63M	0.0%	-13.0%	1.456%
11/15/2021	Pura Vida Investments LLC	114,343	$0.83M	0.0%	-20.1%	0.183%
11/15/2021	Voya Investment Management LLC	13,813	$0.10M	0.0%	-87.9%	0.022%
11/15/2021	Martingale Asset Management L P	15,615	$0.11M	0.0%	N/A	0.025%
11/12/2021	Trexquant Investment LP	12,442	$91K	0.0%	N/A	0.020%
11/12/2021	MCF Advisors LLC	66,185	$0.48M	0.0%	+80.1%	0.106%
11/10/2021	Goldman Sachs Group Inc.	57,175	$0.42M	0.0%	+65.9%	0.092%
11/9/2021	BlackRock Inc.	2,533,139	$18.47M	0.0%	-0.3%	4.063%
11/8/2021	Russell Investments Group Ltd.	37,662	$0.27M	0.0%	-3.7%	0.060%
11/5/2021	Advisory Services Network LLC	268,290	$1.96M	0.1%	+4.5%	0.430%
11/5/2021	Privium Fund Management UK Ltd	48,470	$0.35M	0.4%	N/A	0.078%
11/2/2021	New York State Common Retirement Fund	20,681	$0.15M	0.0%	+43.1%	0.033%
11/1/2021	SG Americas Securities LLC	21,323	$0.16M	0.0%	N/A	0.034%
9/3/2021	Parametric Portfolio Associates LLC	36,961	$0.37M	0.0%	N/A	0.059%
8/17/2021	Millennium Management LLC	1,046,123	$10.48M	0.0%	-40.7%	1.683%
8/17/2021	Balyasny Asset Management LLC	80,202	$0.80M	0.0%	N/A	0.129%

Data available starting January 2016

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company's development candidates for Heme Malignancies includes P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; P-CD19CD20-ALLO1, which is in Phase I trial for treating B cell malignancies and other autoimmune diseases; P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for treating multiple myeloma; and P-CD70-ALLO1 under preclinical development to treat hematological indications. It is also involved in the development of P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, colorectal, lung, ovarian, pancreatic, and renal cancers; P-PSMA-ALLO1, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in preclinical development for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC); and P-PSMA-101, an allogeneic CAR-T product candidate under Phase 1 clinical trial for treating mCRPC. In addition, the company engages in the development of P-FVIII-101, a clinical stage liver-directed gene therapy for the in vivo treatment of hemophilia A; P-OTC-101, a clinical stage liver-directed gene therapy for the in vivo treatment of ornithine transcarbamylase deficiency; and P-PAH-101, a clinical stage liver-directed gene therapy for the in vivo treatment of phenylketonuria. It has a research collaboration and license agreement with F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. The company was incorporated in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $2.05

$1.98

$2.08

50 Day Range

MA: $3.07

$2.00

$4.13

52 Week Range

Now: $2.05

$1.54

$4.27

Volume

283,232 shs

Average Volume

698,545 shs

Market Capitalization

$197.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Poseida Therapeutics?: Poseida Therapeutics' top insider shareholders include:
Life Sciences Holdings L Malin (Major Shareholder)
Eric Ostertag (Chairman)
Learn More about top insider investors at Poseida Therapeutics.